Apical periodontitis progression is impaired by celecoxib and indomethacin treatment (2020)
Source: Abstract Book. Conference titles: International Association of Paediatric Dentistry. Unidades: FORP, FCFRP
Subjects: PERIODONTITE PERIAPICAL, CANAL RADICULAR, LIPOPOLISSACARÍDEOS, REABSORÇÃO ÓSSEA ALVEOLAR
ABNT
ALMEIDA JUNIOR, Luciano Aparecido de et al. Apical periodontitis progression is impaired by celecoxib and indomethacin treatment. 2020, Anais.. Geneva: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, 2020. . Acesso em: 03 set. 2024.APA
Almeida Junior, L. A. de, Petean, I. B. F., Arnez, M. F. M., Queiroz, A. M. de, Silva, R. A. B. da, Silva, L. A. B. da, et al. (2020). Apical periodontitis progression is impaired by celecoxib and indomethacin treatment. In Abstract Book. Geneva: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo.NLM
Almeida Junior LA de, Petean IBF, Arnez MFM, Queiroz AM de, Silva RAB da, Silva LAB da, Faccioli LH, Paula-Silva FWG de. Apical periodontitis progression is impaired by celecoxib and indomethacin treatment. Abstract Book. 2020 ;[citado 2024 set. 03 ]Vancouver
Almeida Junior LA de, Petean IBF, Arnez MFM, Queiroz AM de, Silva RAB da, Silva LAB da, Faccioli LH, Paula-Silva FWG de. Apical periodontitis progression is impaired by celecoxib and indomethacin treatment. Abstract Book. 2020 ;[citado 2024 set. 03 ]